文献速递免疫规划妇幼与学校卫生

增加接种剂量对孟加拉国达卡婴儿口服轮状病毒疫苗应答的影响:一项双盲、平行组、随机对照试验

The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
PubMed 文献 · Vaccine · 2019-10-10

在孟加拉国达卡城市贫民窟开展双盲平行组随机对照试验,220名健康婴儿随机接受标准剂量或双倍标准剂量口服Rotarix疫苗。结果显示双倍剂量未提高疫苗应答(67% vs 71%,RR 0.92,95%CI 0.67-1.24),但疫苗复制阳性婴儿的RV-IgA应答显著增强,且未发现相关严重不良事件。

要点

  • 双倍标准剂量口服Rotarix疫苗未改善婴儿疫苗应答。
  • 疫苗应答率:高剂量组67%,标准剂量组71%(RR 0.92,95%CI 0.67-1.24)。
  • 疫苗复制阳性婴儿RV-IgA应答显著增强,独立于干预分组。

核心结论

  • 给予双倍标准剂量口服减毒活轮状病毒疫苗(Rotarix)未改善孟加拉国达卡城市婴儿的疫苗应答,但疫苗复制阳性儿童免疫原性增强,提示需促进宿主体内复制和改善肠道健康以提高低收入环境口服疫苗应答。

研究设计与样本

  • 双盲、平行组、随机对照试验,2017年6月至2018年6月在孟加拉国达卡Mirpur城市贫民窟开展,220名健康婴儿随机(110例/组)在6周和10周龄接受标准剂量或双倍标准剂量口服Rotarix(葛兰素史克)疫苗。

主要发现

  • 疫苗应答(主要结局):高剂量组62例(67%) vs 标准剂量组69例(71%),RR 0.92(95%CI 0.67-1.24),组间无显著差异。
  • 符合方案完成研究:标准剂量组97例,高剂量组92例。
  • 事后分析中,疫苗复制阳性儿童RV-IgA应答显著增强,独立于干预分组。
  • 未检测到与研究参与相关的严重不良事件。

关键数值与推荐

  • 疫苗应答定义为第二剂后4周实时逆转录聚合酶链反应检出接种后粪便疫苗排毒并经序列确认,或血浆轮状病毒特异性免疫球蛋白A(RV-IgA)血清阳转。
  • 排除标准包括先天畸形、出生或入组体重<2000克、已知免疫受损状况、入组其他疫苗试验或家庭成员已入组本研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 事后分析中疫苗复制阳性儿童RV-IgA应答增强的发现需进一步研究以促进宿主体内复制和改善肠道健康。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oral, live-attenuated rotavirus vaccines suffer from impaired immunogenicity and efficacy in low-income countries. Increasing the inoculum of vaccine might improve vaccine response, but this approach has been inadequately explored in low-income countries. METHODS: We performed a double-blind, parallel group, randomized controlled trial from June 2017 through June 2018 in the urban Mirpur slum of Dhaka, Bangladesh to compare vaccine take (primary outcome) among healthy infants randomized to receive either the standard dose or double the standard dose of oral Rotarix (GlaxoSmithKline) vaccine at 6 and 10 weeks of life. Infants with congenital malformations, birth or enrollment weight <2000 gm, known immunocompromising condition, enrollment in another vaccine trial, or other household member enrolled in the study were excluded. Infants were randomized using random permuted blocks. Vaccine take was defined as detection of post-vaccination fecal vaccine shedding by real-time reverse transcription polymerase chain reaction with sequence confirmation or plasma rotavirus-specific immunoglobulin A (RV-IgA) seroconversion 4 weeks following the second dose. RESULTS: 220 infants were enrolled and randomized (110 per group). 97 standard-dose and 92 high-dose infants completed the study per-protocol. For the primary outcome, no significant difference was observed between groups: vaccine take occurred in 62 (67%) high-dose infants versus 69 (71%) standard-dose infants (RR 0.92, 95% CI 0.67-1.24). However, in post-hoc analysis, children with confirmed vaccine replication had significantly increased RV-IgA responses, independent of the intervention. No significant adverse events related to study participation were detected. CONCLUSIONS: Administration of double the standard dose of an oral, live-attenuated rotavirus vaccine (Rotarix) did not improve vaccine take among infants in urban Dhaka, Bangladesh. However, improved immunogenicity in children with vaccine replication irrespective of initial inoculum provides further evidence for the need to promote in-host replication and improved gut health to improve oral vaccine response in low-income settings. ClinicalTrials.gov: NCT02992197.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lee B, Dickson DM, Alam M, et al. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial. Vaccine. 2019. PMID: 31607603. doi:10.1016/j.vaccine.2019.09.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。